Interestingly, in 2015, Panett et al. [134] already reported on the role of SLC44A1 in pancreatic ductal adenocarcinoma, proposing its role as a suitable molecular marker [134]. The gene discussed is SLC44A1; the disease is pancreatic ductal adenocarcinoma.